A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)

NCT00248183 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

310

Enrollment

INDUSTRY

Sponsor class

Conditions

Anxiety Disorders

Interventions

DRUG: PRX-00023

Sponsor

Epix Pharmaceuticals, Inc.